New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
07:05 EDTFMIFoundation Medicine says new clinical data to be presented at ASCO
Foundation Medicine announced new data demonstrating that FoundationOne identified actionable genomic alterations in a broad range of pediatric cancers. These data will be presented today in a poster highlights presentation at the 2014 American Society of Clinical Oncology Annual Meeting, abstract number 10035. Fully informative genomic profiling was conducted using FoundationOne on 400 pediatric tumors from patients 21 years old or younger at the time of sample procurement. Genomic alterations were identified in a majority of 326 unselected pediatric cancer clinical cases, and 241 of these patients were found to have at least one alteration targeted by an approved therapy or investigational therapy in clinical trials. These results suggest that routine use of accurate, comprehensive genomic profiling with FoundationOne or FoundationOne Heme in pediatric patients may inform treatment options.
News For FMI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 19, 2015
07:27 EDTFMIFoundation Medicine has a conference call hosted by JPMorgan
Subscribe for More Information
May 13, 2015
07:28 EDTFMIFoundation Medicine price target lowered to $48-52 from $60-65 at Wells Fargo
Subscribe for More Information
07:06 EDTFMIFoundation Medicine announces new data on FoundationOne assay
Subscribe for More Information
May 12, 2015
08:20 EDTFMIFoundation Medicine weakness creates buying opportunity, says JMP Securities
Subscribe for More Information
May 11, 2015
18:29 EDTFMIAffordable Care Act guidance says insurers must cover BRCA1, BRCA2 testing
The United States Department of Labor issued updated Affordable Care Act guidance, which mandates that health insurers must cover testing for breast and ovarian cancer through analysis of the BRCA1 and BRCA2 genes. Myriad (MYGN), Foundation Medicine (FMI), and Genomic Health (GHDX) compete in the genetic testing space. Reference Link
16:03 EDTFMIFoundation Medicine reports 7,854 clinical tests in Q1, up 67% y/y
Subscribe for More Information
16:02 EDTFMIFoundation Medicine sees FY15 revenue $105M-$115M, consensus $108.73M
Subscribe for More Information
16:01 EDTFMIFoundation Medicine reports Q1 EPS (59c), consensus (53c)
Reports Q1 revenue $19.3M, consensus $20.98M.
15:00 EDTFMINotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use